Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Drug of Abuse Testing Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for drug abuse treatment
5.1.1.2. Stringent law mandating alcohol and drug testing
5.1.1.3. Increasing drug-related mortality rate and government initiative
5.1.2. Restraints
5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
5.1.3. Opportunities
5.1.3.1. Introduction to innovative and user-friendly disposable products
5.1.3.2. Technological advancements in drug testing
5.1.4. Challenges
5.1.4.1. Possibilities of false-positive test
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Drug of Abuse Testing Market, by Component
6.1. Introduction
6.2. Analyzers
6.3. Consumables
6.4. Laboratory Services
6.5. Rapid Testing Devices

7. Drug of Abuse Testing Market, by Sample Type
7.1. Introduction
7.2. Blood
7.3. Hair
7.4. Oral Fluids
7.5. Sweat
7.6. Urine

8. Drug of Abuse Testing Market, by End User
8.1. Introduction
8.2. Criminal Justice Systems & Law Enforcement Agencies
8.3. Hospitals
8.4. Research Laboratories
8.5. Workplace & School

9. Americas Drug of Abuse Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Drug of Abuse Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Drug of Abuse Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Bio-Rad Laboratories, Inc.
13.1.3. Clinical Reference Laboratory, Inc.
13.1.4. Danaher Corporation
13.1.5. Drgerwerk AG & Co. KGaA
13.1.6. Express Diagnostics International
13.1.7. F. Hoffmann-La Roche Ltd
13.1.8. GE Healthcare Inc.
13.1.9. Laboratory Corporation of America Holdings
13.1.10. Legacy Healthcare Services, Inc.
13.1.11. Mayo Collaborative Services, Inc.
13.1.12. Merck KGaA
13.1.13. Pfizer Inc.
13.1.14. Precision Diagnostic Services Inc
13.1.15. Psychemedics Corporation
13.1.16. Quest Diagnostics
13.1.17. Sanofi SA
13.1.18. Siemens Healthineers AG
13.1.19. Thermo Fisher Scientific Inc
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG OF ABUSE TESTING MARKET DYNAMICS
FIGURE 7. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 10. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 11. DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE & SCHOOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 32. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 35. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 49. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 52. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 58. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 76. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 89. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 113. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 116. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 119. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 131. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 140. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. DRUG OF ABUSE TESTING MARKET LICENSE & PRICING